Implant for Ocular Hypertension, Glaucoma Gets FDA Green Light A single travoprost implant proved noninferior to timolol eye drops, with good safety Dec 14, 2023
First Pulsed Field Ablation Catheter Approved for Afib Device is the first of a new class of non-thermal ablation catheters to get FDA's blessing Dec 14, 2023
FDA OKs Maintenance Option for High-Risk Neuroblastoma Eflornithine approved to reduce relapse risk in both kids and adults Dec 14, 2023
The FDA's Inequitable Conduct Problem Study finds that about half of all inequitable conduct cases were for FDA-regulated products Dec 12, 2023 video
A Closer Look at the Approval of CRISPR/Cas9 Gene Therapy for Sickle Cell Disease This landmark event brings up broader considerations and implications for other diseases Dec 11, 2023
FDA Inspections of Foreign Drug Manufacturers Haven't Bounced Back After Pandemic Overseas inspections "well below" pre-pandemic surveillance Dec 08, 2023
Milestone Gene Therapies for Sickle Cell Disease Greenlit by FDA Casgevy and Lyfgenia approved for one-time treatment of sickle cell disease Dec 08, 2023
FDA Clears First At-Home Kit for Artificial Insemination Intravaginal device was deemed "substantially equivalent" to clinically used intrauterine device Dec 07, 2023
FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuria Iptacopan tops C5 Inhibitors for sustained hemoglobin levels, eliminating need for transfusion Dec 06, 2023
Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxes Health news and commentary from around the Web gathered by 51˶ staff Dec 06, 2023
Jamie Foxx's Health Scare; 23andMe Hacked; Decongestant Probe Announced Health news and commentary from around the Web gathered by 51˶ staff Dec 05, 2023
Don't Neglect Tobacco Use in People Experiencing Homelessness Cessation programs can save lives and improve financial stability Dec 04, 2023
Gaming the Patent System Can Keep Biosimilars Off the Market for Decades Sean Tu, PhD, JD, explains trade secret laws and patent laws for biologics Dec 04, 2023 video
Non-Covalent BTK Inhibitor Approved for CLL Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
FDA Clears First Oral Device Treatment for Severe Sleep Apnea Oral appliances represent an alternative to CPAP and surgical neurostimulation implants Nov 30, 2023
FDA Warns That Philips' CPAP Machines May Overheat Thermal issues including burns, smoke, fire among reports submitted by DreamStation 2 users Nov 29, 2023
FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs Prescribing information changed for levetiracetam, clobazam Nov 28, 2023
FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
FDA Approves First Therapy for Progressive Desmoid Tumors Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
Biden Administration Announces Actions to Strengthen the Drug Supply Chain Biden will use the Defense Production Act to increase American production of some medications Nov 27, 2023
What to Know About Ongoing Eye Drop Recalls FDA was spurred into action by a deadly bacterial outbreak earlier this year, advocates say Nov 20, 2023
Drug Candidate for Chronic Cough Rejected by FDA Panel Gefapixant's benefit not clinically meaningful enough, panelists say Nov 17, 2023
First AKT Inhibitor Approved for Advanced Breast Cancer Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023
Opioid Doc Sentenced; World's First Sickle Cell Gene Tx; FTC Warns Diet Influencers Health news and commentary from around the Web gathered by 51˶ staff Nov 17, 2023
FDA Panel: Tolerating Approval Outliers Would Set 'Dangerous Precedent' No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval Nov 16, 2023
First At-Home Test for Chlamydia and Gonorrhea Authorized by FDA OTC option arrives amid rising cases of the sexually transmitted infections Nov 16, 2023
FDA OKs New Option for Advanced ROS1-Positive Lung Cancer Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
Unclear if Chronic Cough Drug Has Meaningful Benefit, FDA Reviewers Say Previously rejected gefapixant will face agency's panel of outside experts on Friday Nov 16, 2023
FDA OKs Product to Thwart Bloodstream Infections During Dialysis Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
Anthrax Guidance Issued; FDA Warns Amazon; AI Deepfakes Challenge Public Health Health news and commentary from around the Web gathered by 51˶ staff Nov 15, 2023
Lymphoma Drug Copanlisib to Be Pulled From U.S. Market Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
Communicating Uncertainty About Drugs Granted Accelerated Approval An education gap exists about "the possibility that these drugs might not work," says expert Nov 13, 2023 video
First Treatment Approved for Genetic Clotting Disorder Adzynma indicated as prophylactic or on-demand enzyme replacement therapy in cTTP Nov 10, 2023
First Chikungunya Vaccine Lands Conditional FDA Approval High level of seroprotection, but adverse reactions warrant postmarketing study Nov 10, 2023
Competing Incentives of the FDA's Accelerated Drug Approval Experts weigh drug availability against possible suboptimal outcomes Nov 09, 2023 video
New Oral Drug Approved for Metastatic Colorectal Cancer In phase III trials of pretreated patients, fruquintinib improved survival versus placebo Nov 09, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
FDA Approves First Renal Denervation System for Hypertension Catheter-based technology will finally enter the market with ultrasound-based device Nov 08, 2023
FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiators With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
Regulation Gap Persists in OTC Eye Care Products Poor oversight, sketchy product information endanger public health, experts say Nov 04, 2023